Precision BioSciences, Inc. DTIL
8.12 USD +1.15 (+16.50%)
At closeNov 5, 2026, 6:16 AM EST
8.38 +0.26 +3.20%
Pre-market · Nov 5, 6:16 AM ET
7.14 Day range 8.13
3.53 52-week range 9.62
- YTD
- +95.19%
- 1 year
- +22.66%
Analyst view
Consensus: buy
Buy
Price target (mean) 33.60 +313.8% upside
Now 8.12
- Target (low)
- 19.00
- Target (mean)
- 33.60
- Target (high)
- 60.00
Ratings (0m) 5 4 buy · 1 hold · 0 sell
- Strong buy1
- Buy3
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -2.95 | -3.12 – -2.77 | 0.00 | 0.0% | 4.28M | -39.3% | 2 |
| Next quarter | -0.39 | -0.39 – -0.39 | 0.00 | 0.0% | 10.00M | -43.1% | 1 |
| Current year | 1.03 | 0.49 – 1.57 | -11.37 | +109.1% | 71.45M | +46.6% | 2 |
| Next year | -8.62 | -11.96 – -5.28 | 1.03 | -936.9% | 20.02M | -72.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 30, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 30, 2024 | Guggenheim | Initiated | — | Buy |
| Apr 17, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 28, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |